Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9284443 | Revue de Pneumologie Clinique | 2005 | 7 Pages |
Abstract
Pulmonary alveolar phospholipoproteinosis is a rare lung disease of unknown cause characterized by surfactant plugging of the alveoli. At the present time, surgical lung biopsy, long considered as the gold standard, is not necessary for positive diagnosis of pulmonary alveolar phospholipoproteinosis when computed tomography anomalies and analysis of bronchial lavage fluids present a typical pattern. Treatment requires abundant lavage, but the demonstration of anti-GM-CSF antibodies in primary forms opens new therapeutic perspectives.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Philippe Delaval, Graziella Brinchault, Romain Corre, Stéphane Jouneau, Catherine Meunier, Eric Briens,